The Five Trends Defining Biotech Financing in 2026
There is much more money available for biopharma and life sciences in Europe than there
There is much more money available for biopharma and life sciences in Europe than there
We are delighted to announce that Javier Arribas has been promoted to Partner at Justin
The European Commission has recently announced that the first Joint Clinical Assessment (JCA) is finalised
“We don’t need to worry about Market Access, once we find a partner, they’ll take
In less than twelve months, the Trump administration turned a contested policy idea into a
December 2025 marked a defining moment in U.S. drug pricing and Medicare reimbursement policy. Alongside